CD34 and acute myeloid leukemia: These observations further support our hypothesis that AML cells and normal CD34+ bone marrow cells differ with regard to integrin function but also iron metabolism (Figure 4) due to an increased expression of transferrin–transferrin receptors in CD34+ cells.